Tapewire

Nasdaq · USD

ISRG

INTUITIVE SURGICAL INC

Export transactions ↓
Tapewire entity
2878
SEC CIK
0001035267
Parsed reports
1,605

Last 12 months

Inside the activity.

0 purchase rows · 74 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025011
Dec 202507
Jan 202606
Feb 202606
Mar 202609
Apr 202602
May 202606
Jun 202607
Jul 202605
Aug 202609
Sep 202606
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 26, 2022 Filed Jul 27, 2022 22:49 UTC
GUTHART GARY SDirector · President & CEO
Exercise / conversionCommon Stock 126,000 $57.48 $7,242,341.40
Disclosure

SEC source: 0001035267-22-000131 · edgardoc.xml · nonDerivative · entry 1

GUTHART GARY S · CIK 0001280628 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,019

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 26, 2023.

Read SEC document
May 11, 2022 Filed May 13, 2022 21:15 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionRestricted Stock Units · Derivative 363 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000117 · edgardoc.xml · derivative · entry 3

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 723

Underlying: Common Stock · 363 shares

Expires 2024-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

F3 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.

Read SEC document
May 11, 2022 Filed May 13, 2022 21:15 UTC
DeSantis RobertEVP & Chief Product Officer
Tax withholdingCommon Stock 169 $210.87 $35,637.03
Disclosure

SEC source: 0001035267-22-000117 · edgardoc.xml · nonDerivative · entry 2

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,768

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

F2 · balance_after: Amount of securities beneficially owned includes 219 net shares from previous vesting.

Read SEC document
May 11, 2022 Filed May 13, 2022 21:15 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionCommon Stock 363 $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000117 · edgardoc.xml · nonDerivative · entry 1

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,937

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

F2 · balance_after: Amount of securities beneficially owned includes 219 net shares from previous vesting.

Read SEC document
April 28, 2022 Filed Apr 29, 2022 22:13 UTC
KANIA DON RDirector
GrantRestricted Stock Units · Derivative 482 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000094 · edgardoc.xml · derivative · entry 2

KANIA DON R · CIK 0001254028 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 482

Underlying: Common Stock · 482 shares

Expires not disclosed

F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Read SEC document
April 28, 2022 Filed Apr 29, 2022 22:13 UTC
KANIA DON RDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 1,448 $0.00 Strike: $243.26 $0.00
Disclosure

SEC source: 0001035267-22-000094 · edgardoc.xml · derivative · entry 1

KANIA DON R · CIK 0001254028 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,448

Underlying: Common Stock · 1,448 shares

Expires 2029-04-27

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.

Read SEC document
April 28, 2022 Filed Apr 29, 2022 22:31 UTC GrantRestricted Stock Units · Derivative 482 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000096 · edgardoc.xml · derivative · entry 2

NACHTSHEIM JAMI K · CIK 0001223017 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 482

Underlying: Common Stock · 482 shares

Expires not disclosed

F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Read SEC document
April 28, 2022 Filed Apr 29, 2022 22:31 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,448 $0.00 Strike: $243.26 $0.00
Disclosure

SEC source: 0001035267-22-000096 · edgardoc.xml · derivative · entry 1

NACHTSHEIM JAMI K · CIK 0001223017 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,448

Underlying: Common Stock · 1,448 shares

Expires 2029-04-27

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.

Read SEC document
April 28, 2022 Filed Apr 29, 2022 22:39 UTC
LEVY ALAN JDirector
GrantRestricted Stock Units · Derivative 482 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000098 · edgardoc.xml · derivative · entry 2

LEVY ALAN J · CIK 0001280627 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 482

Underlying: Common Stock · 482 shares

Expires not disclosed

F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Read SEC document
April 28, 2022 Filed Apr 29, 2022 22:39 UTC
LEVY ALAN JDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 1,448 $0.00 Strike: $243.26 $0.00
Disclosure

SEC source: 0001035267-22-000098 · edgardoc.xml · derivative · entry 1

LEVY ALAN J · CIK 0001280627 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,448

Underlying: Common Stock · 1,448 shares

Expires 2029-04-27

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.

Read SEC document
April 28, 2022 Filed Apr 29, 2022 22:44 UTC GrantRestricted Stock Units · Derivative 655 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000100 · edgardoc.xml · derivative · entry 2

BARRATT CRAIG H · CIK 0001277620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 655

Underlying: Common Stock · 655 shares

Expires not disclosed

F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

F3 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Read SEC document
April 28, 2022 Filed Apr 29, 2022 22:44 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,965 $0.00 Strike: $243.26 $0.00
Disclosure

SEC source: 0001035267-22-000100 · edgardoc.xml · derivative · entry 1

BARRATT CRAIG H · CIK 0001277620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,965

Underlying: Common Stock · 1,965 shares

Expires 2029-04-27

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.

Read SEC document
April 28, 2022 Filed Apr 29, 2022 22:49 UTC GrantRestricted Stock Units · Derivative 482 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000102 · edgardoc.xml · derivative · entry 2

Reed Monica P · CIK 0001854171 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 482

Underlying: Common Stock · 482 shares

Expires not disclosed

F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Read SEC document
April 28, 2022 Filed Apr 29, 2022 22:49 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,448 $0.00 Strike: $243.26 $0.00
Disclosure

SEC source: 0001035267-22-000102 · edgardoc.xml · derivative · entry 1

Reed Monica P · CIK 0001854171 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,448

Underlying: Common Stock · 1,448 shares

Expires 2029-04-27

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.

Read SEC document
April 28, 2022 Filed Apr 29, 2022 22:57 UTC GrantRestricted Stock Units · Derivative 482 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000104 · edgardoc.xml · derivative · entry 2

RUBASH MARK J · CIK 0001209186 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 482

Underlying: Common Stock · 482 shares

Expires not disclosed

F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Read SEC document
April 28, 2022 Filed Apr 29, 2022 22:57 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,448 $0.00 Strike: $243.26 $0.00
Disclosure

SEC source: 0001035267-22-000104 · edgardoc.xml · derivative · entry 1

RUBASH MARK J · CIK 0001209186 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,448

Underlying: Common Stock · 1,448 shares

Expires 2029-04-27

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.

Read SEC document
April 28, 2022 Filed Apr 29, 2022 23:56 UTC GrantRestricted Stock Units · Derivative 482 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000106 · edgardoc.xml · derivative · entry 2

Johnson Amal M · CIK 0001388397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 482

Underlying: Common Stock · 482 shares

Expires not disclosed

F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

F3 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Read SEC document
April 28, 2022 Filed Apr 29, 2022 23:56 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,448 $0.00 Strike: $243.26 $0.00
Disclosure

SEC source: 0001035267-22-000106 · edgardoc.xml · derivative · entry 1

Johnson Amal M · CIK 0001388397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,448

Underlying: Common Stock · 1,448 shares

Expires 2029-04-27

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.

Read SEC document
April 28, 2022 Filed May 2, 2022 15:27 UTC GrantRestricted Stock Units · Derivative 482 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000108 · edgardoc.xml · derivative · entry 2

Beery Joseph C · CIK 0001249557 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 482

Underlying: Common Stock · 482 shares

Expires not disclosed

F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

F3 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Read SEC document
April 28, 2022 Filed May 2, 2022 15:27 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,448 $0.00 Strike: $243.26 $0.00
Disclosure

SEC source: 0001035267-22-000108 · edgardoc.xml · derivative · entry 1

Beery Joseph C · CIK 0001249557 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,448

Underlying: Common Stock · 1,448 shares

Expires 2029-04-27

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.

Read SEC document
April 28, 2022 Filed May 2, 2022 15:33 UTC GrantRestricted Stock Units · Derivative 482 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000110 · edgardoc.xml · derivative · entry 2

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 482

Underlying: Common Stock · 482 shares

Expires not disclosed

F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Read SEC document
April 28, 2022 Filed May 2, 2022 15:33 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,448 $0.00 Strike: $243.26 $0.00
Disclosure

SEC source: 0001035267-22-000110 · edgardoc.xml · derivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,448

Underlying: Common Stock · 1,448 shares

Expires 2029-04-27

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.

Read SEC document
April 28, 2022 Filed May 2, 2022 15:38 UTC
Ladd Amy LDirector
GrantRestricted Stock Units · Derivative 482 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000112 · edgardoc.xml · derivative · entry 2

Ladd Amy L · CIK 0001781750 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 482

Underlying: Common Stock · 482 shares

Expires not disclosed

F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

F3 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Read SEC document
April 28, 2022 Filed May 2, 2022 15:38 UTC
Ladd Amy LDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 1,448 $0.00 Strike: $243.26 $0.00
Disclosure

SEC source: 0001035267-22-000112 · edgardoc.xml · derivative · entry 1

Ladd Amy L · CIK 0001781750 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,448

Underlying: Common Stock · 1,448 shares

Expires 2029-04-27

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.

Read SEC document
April 27, 2022 Filed Apr 27, 2022 22:28 UTC
Curet MyriamEVP & Chief Medical Officer
GiftCommon Stock 144 $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000092 · edgardoc.xml · nonDerivative · entry 3

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217

F2 · kind: The filer gifted 144 shares to Bryn Mawr College.

Read SEC document
April 26, 2022 Filed Apr 27, 2022 22:28 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 6,000 $0.00 Strike: $139.52 $0.00
Disclosure

SEC source: 0001035267-22-000092 · edgardoc.xml · derivative · entry 4

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 6,000 shares

Expires 2028-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 9, 2022.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
April 26, 2022 Filed Apr 27, 2022 22:28 UTC
Curet MyriamEVP & Chief Medical Officer
SaleCommon Stock 6,000 $252.51 $1,515,058.20
Disclosure

SEC source: 0001035267-22-000092 · edgardoc.xml · nonDerivative · entry 2

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 361

F1 · kind: These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 9, 2022.

Read SEC document
April 26, 2022 Filed Apr 27, 2022 22:28 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionCommon Stock 6,000 $139.52 $837,120.00
Disclosure

SEC source: 0001035267-22-000092 · edgardoc.xml · nonDerivative · entry 1

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,361

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 9, 2022.

Read SEC document
April 26, 2022 Filed Apr 28, 2022 00:45 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 795 $0.00 Strike: $245.60 $0.00
Disclosure

SEC source: 0001567619-22-009055 · doc1.xml · derivative · entry 12

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,750

Underlying: Common Stock · 795 shares

Expires 2031-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48 monthly thereafter.

Read SEC document
April 26, 2022 Filed Apr 28, 2022 00:45 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 270 $0.00 Strike: $242.34 $0.00
Disclosure

SEC source: 0001567619-22-009055 · doc1.xml · derivative · entry 11

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,082

Underlying: Common Stock · 270 shares

Expires 2030-08-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
April 26, 2022 Filed Apr 28, 2022 00:45 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 273 $0.00 Strike: $179.70 $0.00
Disclosure

SEC source: 0001567619-22-009055 · doc1.xml · derivative · entry 10

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,262

Underlying: Common Stock · 273 shares

Expires 2030-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time.

Read SEC document
April 26, 2022 Filed Apr 28, 2022 00:45 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 273 $0.00 Strike: $177.99 $0.00
Disclosure

SEC source: 0001567619-22-009055 · doc1.xml · derivative · entry 9

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,085

Underlying: Common Stock · 273 shares

Expires 2030-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48 monthly thereafter.

Read SEC document
April 26, 2022 Filed Apr 28, 2022 00:45 UTC
DeSantis RobertEVP & Chief Product Officer
SaleCommon Stock 273 $253.04 $69,079.92
Disclosure

SEC source: 0001567619-22-009055 · doc1.xml · nonDerivative · entry 8

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,355

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document
April 26, 2022 Filed Apr 28, 2022 00:45 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionCommon Stock 273 $177.99 $48,590.37
Disclosure

SEC source: 0001567619-22-009055 · doc1.xml · nonDerivative · entry 7

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,628

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document
April 26, 2022 Filed Apr 28, 2022 00:45 UTC
DeSantis RobertEVP & Chief Product Officer
SaleCommon Stock 273 $253.04 $69,079.92
Disclosure

SEC source: 0001567619-22-009055 · doc1.xml · nonDerivative · entry 6

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,355

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document
April 26, 2022 Filed Apr 28, 2022 00:45 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionCommon Stock 273 $179.70 $49,058.10
Disclosure

SEC source: 0001567619-22-009055 · doc1.xml · nonDerivative · entry 5

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,628

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document
April 26, 2022 Filed Apr 28, 2022 00:45 UTC
DeSantis RobertEVP & Chief Product Officer
SaleCommon Stock 270 $253.04 $68,320.80
Disclosure

SEC source: 0001567619-22-009055 · doc1.xml · nonDerivative · entry 4

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,355

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document
April 26, 2022 Filed Apr 28, 2022 00:45 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionCommon Stock 270 $242.34 $65,430.91
Disclosure

SEC source: 0001567619-22-009055 · doc1.xml · nonDerivative · entry 3

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,625

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document
April 26, 2022 Filed Apr 28, 2022 00:45 UTC
DeSantis RobertEVP & Chief Product Officer
SaleCommon Stock 795 $253.04 $201,166.80
Disclosure

SEC source: 0001567619-22-009055 · doc1.xml · nonDerivative · entry 2

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,355

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document
April 26, 2022 Filed Apr 28, 2022 00:45 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionCommon Stock 795 $245.60 $195,252.00
Disclosure

SEC source: 0001567619-22-009055 · doc1.xml · nonDerivative · entry 1

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,150

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document
April 22, 2022 Filed Apr 26, 2022 16:36 UTC
LEVY ALAN JDirector
Exercise / conversionRestricted Stock Units · Derivative 555 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001567619-22-008942 · doc1.xml · derivative · entry 2

LEVY ALAN J · CIK 0001280627 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 555 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of the Stockholders, subject to the Reporting Person's continued service.

F1 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of the Stockholders, subject to the Reporting Person's continued service.

Read SEC document
April 22, 2022 Filed Apr 26, 2022 16:36 UTC
LEVY ALAN JDirector
Exercise / conversionCommon Stock 555 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-008942 · doc1.xml · nonDerivative · entry 1

LEVY ALAN J · CIK 0001280627 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,837

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 22, 2022 Filed Apr 26, 2022 16:36 UTC Exercise / conversionRestricted Stock Units · Derivative 555 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001567619-22-008943 · doc1.xml · derivative · entry 2

Johnson Amal M · CIK 0001388397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 555 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of the Stockholders, subject to the Reporting Person's continued service.

F1 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of the Stockholders, subject to the Reporting Person's continued service.

Read SEC document
April 22, 2022 Filed Apr 26, 2022 16:36 UTC Exercise / conversionCommon Stock 555 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-008943 · doc1.xml · nonDerivative · entry 1

Johnson Amal M · CIK 0001388397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,224

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 22, 2022 Filed Apr 26, 2022 16:37 UTC
Ladd Amy LDirector
Exercise / conversionRestricted Stock Units · Derivative 555 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001567619-22-008944 · doc1.xml · derivative · entry 2

Ladd Amy L · CIK 0001781750 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 555 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of the Stockholders, subject to the Reporting Person's continued service.

F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of the Stockholders, subject to the Reporting Person's continued service.

F1 · balance_after: On October 5, 2021, the common stock equity grants of Intuitive Surgical split 3-for-1, resulting in the Reporting Person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock grants to decrease to 1/3rd of the original grant price.

Read SEC document
April 22, 2022 Filed Apr 26, 2022 16:37 UTC
Ladd Amy LDirector
Exercise / conversionCommon Stock 555 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-008944 · doc1.xml · nonDerivative · entry 1

Ladd Amy L · CIK 0001781750 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,320

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: On October 5, 2021, the common stock equity grants of Intuitive Surgical split 3-for-1, resulting in the Reporting Person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock grants to decrease to 1/3rd of the original grant price.

Read SEC document
April 22, 2022 Filed Apr 26, 2022 16:38 UTC Exercise / conversionRestricted Stock Units · Derivative 753 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001567619-22-008945 · doc1.xml · derivative · entry 2

BARRATT CRAIG H · CIK 0001277620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 753 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of the Stockholders, subject to the Reporting Person's continued service.

F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of the Stockholders, subject to the Reporting Person's continued service.

F1 · balance_after: On October 5, 2021, the common stock equity grants of Intuitive Surgical split 3-for-1, resulting in the Reporting Person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock grants to decrease to 1/3rd of the original grant price.

Read SEC document
April 22, 2022 Filed Apr 26, 2022 16:38 UTC Exercise / conversionCommon Stock 753 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-008945 · doc1.xml · nonDerivative · entry 1

BARRATT CRAIG H · CIK 0001277620 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 24,696

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: On October 5, 2021, the common stock equity grants of Intuitive Surgical split 3-for-1, resulting in the Reporting Person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock grants to decrease to 1/3rd of the original grant price.

Read SEC document
April 22, 2022 Filed Apr 26, 2022 16:39 UTC
KANIA DON RDirector
Exercise / conversionRestricted Stock Units · Derivative 555 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001567619-22-008946 · doc1.xml · derivative · entry 2

KANIA DON R · CIK 0001254028 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 555 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of the Stockholders, subject to the Reporting Person's continued service.

F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of the Stockholders, subject to the Reporting Person's continued service.

F1 · balance_after: On October 5, 2021, the common stock equity grants of Intuitive Surgical split 3-for-1, resulting in the Reporting Person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock grants to decrease to 1/3rd of the original grant price.

Read SEC document
April 22, 2022 Filed Apr 26, 2022 16:39 UTC
KANIA DON RDirector
Exercise / conversionCommon Stock 555 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-008946 · doc1.xml · nonDerivative · entry 1

KANIA DON R · CIK 0001254028 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,787

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: On October 5, 2021, the common stock equity grants of Intuitive Surgical split 3-for-1, resulting in the Reporting Person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock grants to decrease to 1/3rd of the original grant price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.